Abstract
Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.
Original language | English |
---|---|
Pages (from-to) | 831-836 |
Number of pages | 6 |
Journal | Antiviral Therapy |
Volume | 18 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2013 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
- Medicine(all)